The fourth Liver Forum was held on April 12, 2016, in Barcelona, Spain.
Materials:
Presentations:
- Liver Forum Welcome, Introduction, and Updates
Veronica Miller, Forum for Collaborative HIV Research - Regulatory Update from Europe: Study Design, Population, Endpoints and Pitfalls of Phase 3 Trials in NASH
Elmer Schabel, Bundesinstitut für Arzneimittel und Medizinprodukte - Working Group Report: Disease Definitions for NAFLD
Mohammad Shadab Siddiqui, Virginia Commonwealth University - Detection and Assessment of Drug Induced Liver Injury (DILI) in NASH Clinical Trials: Key Questions and Future Challenges
Arie Regev, Eli Lilly and Company - Baseline Parameters for NAFLD/ NASH Clinical Trials
Claudia Filozof, Covance - Pediatric Issues Working Group: Definitions and Baseline Parameters
Joel Lavine, Columbia University Medical Center
Miriam Vos, Emory University School of Medicine - Mapping Potential Placebo Arm Cohort
Veronica Miller, Forum for Collaborative HIV Research - Targeted Learning Methods for Challenges in Liver Diseases
Mark van der Laan, UC Berkeley Center for Targeted Learning in Big Data - My Own Med: Innovative Data Collection Approaches to Support RWE
Trang Gisler, My Own Med, Inc
